Skip to main content
. 2020 Feb 22;13:13. doi: 10.1186/s13045-020-0846-y

Fig. 1.

Fig. 1

Metastasis-free survival (MFS) and overall survival (OS) in 323 different subtypes of TNBC (198 of no special type, 43 apocrine, 36 medullary, 13 metaplastic, and 33 rare TNBCs) analyzed in log-rank tests